We have demonstrated that SCASA yeast can effectively simulate CD19+ cancer cells with precise on-demand antigen densities that control the activational state of CAR T cells, allowing for high-resolution interrogation of CAR T cell responses (Figs. 3–5). The gene discussed is CD19; the disease is cancer.